首页> 美国卫生研究院文献>Neuro-oncology Advances >32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
【2h】

32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES

机译:32.使用脑转移患者氨基酸宠物治疗免疫疗法和靶向治疗的治疗监测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently, the RANO group has analyzed the additional diagnostic value of amino acid PET in patients with primary and secondary brain tumors and recommended the use of this imaging technique in addition to conventional MRI. Here, we investigated the value of PET using the radiolabled amino acid O-(2-[ F]fluoroethyl)-L-tyrosine (FET) for treatment monitoring of immune checkpoint inhibition (ICI) or targeted therapy (TT) alone or in combination with radiotherapy in patients with brain metastases (BM) since contrast-enhanced MRI often remains inconclusive.
机译:最近,RANO组已经分析了初级和继发性脑肿瘤患者氨基酸PET的额外诊断价值,并推荐使用这种成像技术除常规MRI之外。在这里,我们研究了使用放射氨基酸O-(2-[F]氟乙基)-1-酪氨酸(FET)来治疗免疫检查点抑制(ICI)或靶向治疗(TT)的治疗或组合的宠物的值随着脑转移患者(BM)的放射疗法,因为对比增强的MRI通常仍然不确定。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号